Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Kairos Pharma Ltd.
KAPA | US
0.61
USD-0.06
-9.24%
KAPA | US
Loading StockChartView...
About Kairos Pharma Ltd.
Sector
BBG01JLR1R85
Industry
BBG01JLR1R85
Earnings date
30/06/2024
As of date
24/04/2026
Close
0.61
Open
0.68
High
0.68
Low
0.61
View Less
KAPA | US
Risk
61.2
Sharpe
-0.29
Luna's Score
36/100
Recommendation
Sell
Luna says (KAPA | US)
What's Working
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
62.6%1 month
61.2%3 months
63.8%6 months
79.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.15
Range1M
0.17
Range3M
0.25
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.50
Price X volume
74.87K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | - | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 63.80 | - | - |
| Debt to Equity | - | - | - |
| Debt to Assets | - | - | - |
| Market Cap | - | - | - |
